Datasets:
id
int64 0
34.5k
| question
stringlengths 7
1.83k
| choice0
stringlengths 1
1k
| choice1
stringlengths 1
984
| choice2
stringlengths 1
1.82k
| choice3
stringlengths 1
1.82k
| choice4
stringlengths 1
1.94k
| label
int64 0
4
| task
stringclasses 3
values |
---|---|---|---|---|---|---|---|---|
15,616 | Prostaglandin E2の異なる表記は? | Pyroracemic acid | Oleandomycin 2'-O-phosphate | Allethrin | PGE2 | Virgaureasaponin I | 3 | replace |
23,431 | エリスロマイシンBの別表現は? | Erythromycin B | SQ 26180 | Chlorfenac | Selenate | Stramonin B | 0 | replace |
29,610 | Pefurazoateの別名は? | 12-epi-Fischerindole G | ぺフラゾエート | 3',4',5'-O-Trimethyltricetin | キシメン酸 | 5-Amino-6-(5'-phospho-D-ribitylamino)uracil | 1 | replace |
21,090 | C35H52O9の異なる表記は? | 4-Substituted anilide | Isospinosin | Avermectin A2a aglycone | Thiopurine | L-カルニチン | 2 | replace |
3,208 | 副甲状腺ホルモン関連ペプチド (1-36)は別の呼び方では? | ジエチルスルフィド | Parathyroid hormone-related peptide (1-36) | trans,octacis-Decaprenylphospho-beta-D-arabinofuranose | セクレチン | Hexahydrocurcumin | 1 | replace |
18,364 | Ipomeamaroneの別の呼び方は? | オリパビン | ストレプチジン 6-リン酸 | alpha-Pyrrolidinohexiophenone | L-Methionine | イポメアマロン | 4 | replace |
12,995 | Penitrem Dの別呼称は? | アナトキシンa | ファストグリーンFCF | メトキサジアゾン | N5-Phenyl-L-glutamine | ペニトレムD | 4 | replace |
23,037 | ベータ-フリーデリノールの別名称は? | Protein-omega-N-(ADP-D-ribosyl)-L-arginine | 5-Amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide | beta-Friedelinol | T-T dimer | (-)-Anatabine | 2 | replace |
29,665 | Lecimibide (USAN)をは化学構造で表すと? | (C9H11N)2. H2SO4 | C7H6O | C34H40F2N4OS | C9H11BrN2O5 | C1575H2400N422O477S6 | 2 | formula |
25,849 | (4S,5S)-(+)-Germacrone 4,5-epoxideの別記述は? | (4S,5S)-(+)-ゲルマクロン 4,5-エポキシド | 17beta-Dihydroequilin | L-Ascorbate 6-phosphate | 7-[(3S)-3-Amino-3-carboxypropyl]-4-demethylwyosine in tRNA(Phe) | alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine | 0 | replace |
14,850 | SHOX-related short stature SUBGROUP Isolated short stature Langer mesomelic dysplasia Leri-Weill dyschondrosteosisの別名称は? | SHOX-関連低身長症 下位グループ 特発性低身長 Langer 中間肢節短縮型形成異常 Leri-Weill 軟骨骨異形成症 | 先天性角化異常症 下位グループ X連鎖先天性角化異常症 (DKCX) 常染色体優性遺伝性先天性角化異常症 (DKCA) 常染色体劣性遺伝性先天性角化異常症 (DKCB) 二遺伝子性遺伝先天性角化異常症 (DKCD) Revesz 症候群 | 前頭側頭葉変性症 下位グループ ピック病 前頭側頭型認知症 (FTD) ユビキチン陽性封入体を伴う前頭側頭葉変性症 (FTLDU) 進行性核上性麻痺 (PSNP) 骨パジェット病および前頭側頭型認知症をともなう封入体ミオパチー 前頭側頭型認知症および筋萎縮性側索硬化症 | Hao-Fountain 症候群 | シラミ症 下位グループ アタマジラミ症 コロモジラミ症 | 0 | replace |
20,571 | C35H34MgN4O6の別呼称は? | cis-4,5-Dihydro-4,5-pyrenediol | 7(1)-Hydroxychlorophyllide a | Bensulfuron-methyl | Chlorendic acid | 6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8,8-tetrachloroocta-2E,4E-dienoate | 1 | replace |
4,369 | メピキサノクスをを組成式で書くと? | C19H20N2O4S | C22H24ClN5O | C11H14N2S. C4H6O6 | C18H24N2O2S. CH4SO3 | C20H21NO3 | 4 | formula |
20,916 | C15H12I3NO4の別呼称は? | ビワヨウ (JP18) | デランゾミブ | 濃グリセリン・果糖 | ウンケイトウ | Liothyronine I 131 (USAN) | 4 | replace |
18,811 | Ethosuximideをを化学式で表すと? | C27H40O5 | C14H14N2O5 | C7H11NO2 | C20H28O2 | C21H16NO5 | 2 | formula |
27,015 | テトラリンをは化学式で表すと? | C16H14F3N5O | C11H17NO | C18H22N2 | C10H12 | C4H8NO7P | 3 | formula |
21,652 | Epichlorohydrinの異なる表記は? | 9,10-Epoxystearate | 6-Demethoxycapillarisin | (2S,3S)-3-Hydroxyasparagine | 1-Chloro-2,3-epoxypropane | Honokiol | 3 | replace |
22,676 | HERCEPTINHYLECTA(Genentech)は別の呼び方では? | Atamparib (USAN/INN) | Trastuzumab and hyaluronidase-oysk | イソフェンインスリン水性懸濁液 (JAN) | 大腹皮 | Prenylamine lactate (JAN) | 1 | replace |
16,684 | C35H34MgN4O5の異なる表記は? | 2-Dehydro-3-deoxy-D-fuconate | Valerate | Kakuol | Chlorophyllide a | 7alpha,12alpha-Dihydroxy-3-oxochol-24-oyl-CoA | 3 | replace |
3,939 | スラルビノンの異なる表現は? | 1-Alkenylglycerophosphoethanolamine | Vanillate | Urolithin A | Soularubinone | 3-Oxopalmitoyl-CoA | 3 | replace |
33,880 | 17beta-Hydroxy-6beta-methyl-5alpha-androstan-3-one propionateの別名称は? | alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein | Fibronectin | Epithienamycin C | 3-Iodo-4-hydroxyphenylpyruvate | 4,5alpha-Dihydro-6beta-methyltestosterone propionate | 4 | replace |
22,632 | Bepio (TN)をの組成式は? | C20H27NO3 | C14H10O4 | C21H27NO. HCl | C6H14N2O2. HCl | C14H16N4O. HCl | 1 | formula |
4,073 | 2',4,4',6'-Tetrahydroxychalcone 4'-O-glucosideをを化学構造で記述すると? | C11H14N2O | C15H23NO2 | C10H6O2 | C21H22O10 | C10H13N5 | 3 | formula |
32,717 | Mifobate (USAN/INN)の別名は? | Ropivacaine (INN) | Cortivazol (USAN) | ミホバート | Lenperone (USAN) | Sodium bicarbonate and bitter tincture (JP18) | 2 | replace |
15,696 | C19H16N6O4Sの別表現は? | Cardura XL (TN) | Technetium Tc 99m sulfur colloid (USP) | Zibotentan (JAN/USAN/INN) | Nifuradene (USAN/INN) | Leniolisib (USAN/INN) | 2 | replace |
26,138 | C5H8N2O5の別名は? | Capillarin | Galantide | Dehydrosecodine | 3-(カルボキシカルボニルアミノ)-L-アラニン | トリウム232 | 3 | replace |
3,818 | C6H10S2は別の呼び方では? | Benzyl thiocyanate | 6-Hydroxykaempferol | Pentazocine | クロルフェネシン | ジアリルジスルフィド | 4 | replace |
17,284 | Cycloeucalenoneをを化学構造で記述すると? | C30H48O | C17H26O3 | C16H14F5N5O5S | C27H46N2O2 | C8H9NO2 | 0 | formula |
6,678 | C34H34MgN4O3の別名称は? | Midazolam | 8,12-Diethyl-3-vinylbacteriochlorophyllide d | (2-Aminobenzoyl)acetate | Morroniside | (Glycerophosphate)n+1 | 1 | replace |
31,078 | S-Adenosyl-(5')-3-methylthiopropylamineの別表現は? | Decarboxy-AdoMet | trans-3-Aminocyclopentane-1-carboxylic acid | (E,E)-2,4-Hexadienal | 5-O-beta-D-Mycaminosyltylonolide | N3-Fumaroyl-(S)-2,3-diaminopropanoate | 0 | replace |
20,309 | Siaresinolの別の言い方は? | Macrophylline | Cyanidin 3-O-3'',6''-O-dimalonylglucoside | beta-D-Glucosaminyl-(1->4)-N-acetyl-D-glucosamine | シブトリン | シアレシノール | 4 | replace |
31,436 | フェチジンの別名は? | 3-O-Sulfated heparan sulfate | Nylon 6 | 11alpha-Hydroxy-17alpha-methyltestosterone | Mg-2,4-divinyl-phaeoporphyrin a5-monomethylester | Fetidine | 4 | replace |
5,705 | アクリル酸ブチルの異なる名称は? | Indoleglycerol phosphate | Malonic acid | Haloacetate | Butyl acrylate | Gemcitabine | 3 | replace |
32,719 | alpha-Hydroxy-p-xyleneの別名は? | 2,2',3,6,6'-Pentachloro-4-biphenylol | N1,N5,N10-Tri(hydroxyferuloyl) spermidine | Nostopeptolide A2 | (-)-threo-1-Hydroxy-1,2,5-pentanetricarboxylic acid | 4-Methylbenzyl alcohol | 4 | replace |
18,606 | C28H47N2O21Rの異なる表現は? | 5-Hydroxypseudobaptigenin | Enteramine | 3-Methylbutan-1-ol | beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R | Aspartate beta-semialdehyde | 3 | replace |
7,769 | C16H19N3Sの別名は? | Isothipendyl (INN) | Etifenin (USAN) | ナフチドロフリル | Cobamamide (JAN/INN) | 滋陰降火湯 | 0 | replace |
19,909 | リスリドをを化学式で書くと? | C18H24N2O2S. CH4SO3 | C20H15F3N4O3. CH4SO3 | C22H16Cl2O4S | C20H26N4O | C19H24N4O3. HCl | 3 | formula |
31,582 | Thiophene-2-carbixylic acidの別名は? | セファパロール | テノ酸 | アトロピン・プラリドキシム塩化物 | Naronapride (USAN/INN) | チゴゼルチニブ | 1 | replace |
28,983 | Landipirdine (USAN/INN)をを分子式で記述すると? | C18H19FN2O3S | C23H31N3O4S2 | C1058H1651N277O341S14 | C42H60O16. 2K | C18H21N5O3 | 0 | formula |
26,479 | C11H8O2の別の呼び方は? | 排膿湯 | メナジオン | Tretoquinol (INN) | 酪酸菌 | ジプレノルフィン塩酸塩 | 1 | replace |
12,379 | C3386H5242N882O1048S16の別表現は? | Lodelaben (USAN/INN) | Pivopril (USAN/INN) | プラウラシン | タルジテルセプトアルファ | Floctafenine (JAN/USAN/INN) | 3 | replace |
30,456 | C92H174N3O26Pの異なる表記は? | H. pylori KDO-lipid A | Anthocyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside | フェニュロン | ヒノキオール | Caffeine | 0 | replace |
27,512 | 1p36 欠失症候群の別呼称は? | 1p36 deletion syndrome | Familial idiopathic basal ganglia calcification | Essential tremor | Syndromic intellectual developmental disorder SUBGROUP IDD with short stature IDD with autism and speech delay IDD and retinitis pigmentosa (IDDRP) IDD with cardiac arrhythmia (IDDCA) IDD with cardiac defects and dysmorphic facies (IDDCDF) IDD with dysmorphic facies and ptosis (IDDFP) IDD with dysmorphic facies, seizures, and distal limb anomalies (IDDFSDA) IDD with persistence of fetal hemoglobin (DILOS) IDD with behavioral abnormalities, craniofacial dysmorphism and seizures (IDDBCS) IDD with dysmorphic facies and behavioral abnormalities (IDDFBA) IDD with epilepsy, behavioral abnormalities, and coarse facies (IDDEBF) IDD with hypertelorism and distinctive facies (IDDHDF) IDD with hypotonia and behavioral abnormalities (IDDHBA) IDD with macrocephaly, seizures, and speech delay (IDDMSSD) IDD with neuropsychiatric features (IDDNPF) IDD with epilepsy or cerebellar ataxia (IDDECA) IDD with seizures and language delay (IDDSELD) IDD with severe speech and ambulation defects (IDDSSAD) IDD with dysmorphic facies, speech delay, and T-cell abnormalities (IDDFSTA) Facial dysmorphism, hypertrichosis, epilepsy, IDD, and gingival overgrowth (FHEIG) Hypotonia, hypoventilation, IDD, dysautonomia, epilepsy, and eye abnormalities (HIDEA) IDD with poor growth and seizures or ataxia (IDPOGSA) IDD with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) IDD with paroxysmal dyskinesia or seizures (IDDPADS) IDD with speech delay and axonal peripheral neuropathy (IDDSAPN) Chopra-Amiel-Gordon syndrome (CAGS) Impaired intellectual development and distinctive facial features with or without cardiac defects (MRFACD) IDD with muscle tone abnormalities and distal skeletal defects (IDDMDS) IDD with ocular anomalies and distinctive facial features (IDDOF) IDD with or without peripheral neuropathy (IDDPN) | Niemann-Pick disease type C SUBGROUP Niemann-Pick disease type C1 Niemann-Pick disease type C2 SUPERGRP Defects in lysosomal trafficking Lysosomal storage disease | 0 | replace |
4,390 | N(G)-Monomethyl-L-arginineの異なる表記は? | Paeonilactone C | D-Xylono-1,4-lactone 5-phosphate | N(omega)-Methyl-L-arginine | コラムビアネチン | 5-Hydroxy-guaiacyl lignin | 2 | replace |
22,663 | Cyclo(L-Trp-L-Phe)をを組成式で表すと? | C20H19N3O2 | C7H5BiO4 | C20H28O10 | C19H20O4 | C10H16O | 0 | formula |
18,371 | Fradiomycin Bの異なる表現は? | (2E,6E)-Farnesol | 7-Methyl-3-oxooctanoyl-CoA | Framycetin | M1 | Propapyriogenin A2 | 2 | replace |
32,421 | N-(Tetradecanoyl)-sphing-4-enineをの化学式は? | C21H28O3 | C16H29N2O11PR2(C5H8O6PR)n | C32H63NO3 | C29H36O17 | C14H20NO4R | 2 | formula |
5,807 | アリセルチブナトリウム水和物の異なる表記は? | Alisertib sodium (USAN) | ピラブロム | リオプロスチル | ファリシマブ (遺伝子組換え) (JAN) | トランスパイオキソカンファー (JAN) | 0 | replace |
24,109 | Evofosfamide (JAN/USAN/INN)の別名称は? | 加減涼膈散 (龔廷賢) | エボホスファミド (JAN) | Bisobrin lactate (USAN) | ゼルバリマブ | 苓姜朮甘湯 | 1 | replace |
6,074 | ガレジェニマブをを化学式で表すと? | C2066H3194N550O673S12 | (C26H36O24)n | C5H5N3O3S | C23H24N6O5S2 | C21H21NO2. C4H4O4 | 0 | formula |
33,971 | インダナゾリンをは分子式で表すと? | C17H26N4O3S2 | C16H25N2O5S. Na | C6514H9974N1706O2056S44 | C12H15N3 | C26H25F3N6O5 | 3 | formula |
17,001 | アダグロキサドシモレニンの別名は? | Adagloxad simolenin (USAN) | ベンラファキシン | アルバメリンマレアート | アンピシリン・ジクロキサシリンナトリウム | Sotalol (INN) | 0 | replace |
12,053 | Delavan (TN)をを組成式で記述すると? | C21H30O3 | C3H6FNO2 | C21H29NO | C28H44NO2. Cl. H2O | C16H20Cl2N2O. C4H4O4 | 3 | formula |
9,638 | KRN 7000をを化学式で書くと? | C12H6Br4O | Na | C7H8N2S. HCl | C50H99NO9 | C4H7N2O6PR2 | 3 | formula |
19,558 | Denufosol tetrasodium (USAN)をを分子式で表すと? | C13H16N2O2. H2SO4 | C18H23N5O21P4. 4Na | C25H17F4N5O2 | C17H12F3NO4S | C14H14N4O3. HCl | 1 | formula |
23,602 | Glyphosate-isopropylammoniumをを分子式で書くと? | C5H8 | C19H30O4 | C15H10O7 | C3H8NO5P. C3H9N | C23H30Br2O3 | 3 | formula |
12,452 | 眼瞼裂狭小・眼瞼下垂・逆内眼角贅皮症候群の異なる名称は? | Vitreoretinal degeneration SUBGROUP Stickler syndrome (STL) Snowflake vitreoretinal degeneration (SVD) Wagner syndrome (WGVRP) Knobloch syndrome (KNO) Enhanced S-cone syndrome (ESCS) Autosomal dominant vitreoretinochoroidopathy (VRCP) | Frontometaphyseal dysplasia | Enteroaggregative Escherichia coli (EAEC) infection | Blepharophimosis-ptosis-epicanthus inversus syndrome | Pachyonychia congenita SUBGROUP Jadassohn-Lewandowsky syndrome Jackson-Lawler syndrome | 3 | replace |
5,899 | C6502H10034N1758O2032S52の別表現は? | ボラギデマブ | クロロピラミン塩酸塩 | Brivanib alaninate (JAN/USAN/INN) | Pembrolizumab (USAN) | ルフォクロモミシン | 0 | replace |
32,622 | Dihydrosamidinの異なる名称は? | Psychosine sulfate | キラ酸 | ジヒドロサミジン | Piproctanyl | p-Hydroxybenzyldesulphoglucosinolate | 2 | replace |
15,568 | C64H107NO16P2の異なる表現は? | Divostroside | パボニニン 1 | Sodium sulfate | alpha-L-Rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol | ホサミン | 3 | replace |
17,842 | C17H20N2O2の別呼称は? | Zerumbone | Tropisetron | エンドセリン-3 | Fasciculol F | ハルホルジノール | 1 | replace |
22,148 | 低カリウム血性周期性四肢麻痺 上位グループ 遺伝性周期性四肢麻痺 の別の言い方は? | Poretti-Boltshauser syndrome | Hypokalemic periodic paralysis SUPERGRP Periodic paralysis | Webb-Dattani syndrome | Familial skewed X-chromosome inactivation | Classic galactosemia | 1 | replace |
23,354 | Focal segmental glomerulosclerosis SUBGROUP Focal segmental glomerulosclerosis and neurodevelopmental syndrome (FSGSNEDS)の別呼称は? | CBL 症候群 | 房室中隔欠損 | Naegeli-Franceschetti-Jadassohn 症候群 | 遠位遺伝性運動ニューロパチー 下位グループ 常染色体優性遺伝性遠位運動ニューロパチー (HMND) 常染色体劣性遺伝性遠位運動ニューロパチー (HMNR) X-連鎖性遺伝性遠位運動ニューロパチー (HMNX) | 巣状分節性糸球体硬化症 下位グループ 巣状分節性糸球体硬化症および神経発達症候群 (FSGSNEDS) | 4 | replace |
27,489 | D-Fructuronic acidをは化学式で表すと? | C19H26N2O | C21H39O7P | C6H10O7 | C44H55CoN4O16 | C15H10O6 | 2 | formula |
31,679 | C10H14N4O3を材料とする製品は? | モノフィリン(日医工) | SOVUNA(ANIPharmaceuticals) | サイコ(東洋漢方製薬) | 後発品SUMATRIPTANANDNAPROXENSODIUM(AurobindoPharmaLimited) | ベニジピン塩酸塩(東和薬品) | 0 | product |
33,583 | cis-4-Carboxymethylene-2-chlorobut-2-en-4-olideは別の呼び方では? | 2S-Hydroxytetradecanoic acid | cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide | Marmesin | Normorphine | L-2-Aminohexanoate | 1 | replace |
33,607 | Alanylphosphateの異なる名称は? | D-Alanyl-phosphate | Reduced rubredoxin | 3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose | (-)-alpha-Amorphene | 2alpha-Methyl-5alpha-androstane-3beta,17beta-diol | 0 | replace |
27,102 | Manganese chloride (USP)を主とした医薬品は? | MANGANESE(Hospira) | AMLODIPINEBESYLATE(PreferredPharmaceuticals) | GENERICPIOGLITAZONEANDGLIMEPIRIDE(PrascoLaboratories) | OSELTAMIVIRPHOSPHATE(TevaPharmaceuticalsUSA) | TRIENTINEHYDROCHLORIDE(RisingPharmaceuticals) | 0 | product |
4,433 | 5-(2'-Carboxyethyl)-4,6-dihydroxypicolinateを言い換えると? | N6'-Acetylkanamycin-B | 2,4-Dichlorotoluene | Products of ATP breakdown | 5-(beta-Carboxyethyl)-4,6-dihydroxypicolinate | Tetrahydrocortisone | 3 | replace |
4,489 | C2H6NRの異なる表記は? | Solasonine | Methylisoeugenol | 3-Fluorobenzoyl-CoA | N-Glucosylnicotinate | 2-Arylethylamine | 4 | replace |
25,765 | ダニリキシンの異なる表現は? | Zotarolimus (USAN/INN) | Trichosanthes fruit | Opipramol dura (TN) | Danirixin (USAN/INN) | 1,3,5-Trimethoxybenzene (JAN) | 3 | replace |
26,997 | C22H32O2の異なる名称は? | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid | 1,5-Anhydro-D-erythro-hex-1-en-3-ulose | Avideoxycholic acid | Staphyloferrin A | 1,2-Dihydroaceanthrylene | 0 | replace |
30,833 | Icatibant acetate (JAN/USAN)を主材料とする薬品は? | ICATIBANT(TevaPharmaceuticalsUSA) | ゾフルーザ(塩野義製薬) | IQIRVO(IpsenBiopharmaceuticals) | FENTANYLCITRATE(PhlowCorp.) | LUBIPROSTONE(Dr.Reddy'sLaboratories) | 0 | product |
8,584 | Enterotoxigenic Escherichia coli (ETEC) infectionの別の呼び方は? | 腸管毒素原性大腸菌感染症 | 白質ジストロフィーを伴う網膜ジストロフィー | 眼歯指異形成症 | 3M 症候群 | 非症候群性先天性ばち指 | 0 | replace |
28,972 | Coal-tar pitchの異なる名称は? | コールタールピッチ | クオーテモン | ピロ炭酸ジエチル | Paclobutrazol | 1-Methoxy-2-hydroxyanthracene | 0 | replace |
25,950 | C10H9NO3の別の呼び方は? | スチピタト酸 | 6alpha-Hydroxycastasterone | 5-Phenyl-1,3-oxazinane-2,4-dione | Ethohexadiol | メスアキサントンB | 2 | replace |
1,847 | C19H21O9SRの別名称は? | カルシセプチン | N5-Phospho-L-glutamine | 3,5,7,9,11,13,15,17-Octaoxo-nonadecanoyl-[acp] | Reduced electron-transferring flavoprotein | alpha-D-Lyxose | 2 | replace |
15,987 | PREGABALINEXTENDEDRELEASE(Alvogen)を用いた商品名は? | ) | キジツ(ウチダ和漢薬) | トウモロコシデンプン(日興製薬) | PREGABALIN(ST.MARY'SMEDICALPARKPHARMACY) | 小建中湯(ツムラ) | 3 | product |
20,924 | C16H19NO3の別名は? | 2,2-Dialkylglycine | alpha-Smegma-mycolic acid | T 0901317 | alpha-Erythroidine | Toxyl angelate | 3 | replace |
12,816 | アルコール塗布の別表現は? | Lifileucel (USAN/INN) | Ifinatamab deruxtecan (genetical recombination) (JAN) | トロピセトロン塩酸塩 (JAN) | トレノナコグアルファ | Alcohol, rubbing (USP) | 4 | replace |
3,805 | cis-3-Chloro-2-propenalの別記述は? | 10-Hydroxydihydrosanguinarine | (-)-Deltoin | cis-3-Chloroallyl aldehyde | Dalfopristin | N-Methylnicotinate | 2 | replace |
26,742 | Dihydrocodeine phosphate, ephedrine hydrochloride and ammmonium chlorideの別呼称は? | ジヒドロコデインリン酸塩・エフェドリン塩酸塩・塩化アンモニウム | 沈降7価肺炎球菌結合型ワクチン (無毒性変異ジフテリア毒素結合体) | ホミカエキス (JP18) | ベスチピタントメシラート | Methaniazide (INN) | 0 | replace |
30,568 | C7H13N2O4PS3の別名は? | 3',4',5-Trihydroxy-3,6,7-trimethoxyflavone | 3-Methylbutanoyl-CoA | trans-p-Nitrostilbene | Iron cyanide (Fe(CN)2) | Lythidathion | 4 | replace |
32,172 | C9H17NO3の異なる名称は? | ラニナミビル | beta-D-Fucoside | Mirasan | Benzimidazole | (8S)-8-Amino-7-oxononanoate | 4 | replace |
14,427 | N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(4-fluorobenzyl)-1H-indazole-3-carboxamideの別の呼び方は? | 2-Amino-5-epi-valiolone | 17alpha,2alpha-Dimethyl-17beta-hydroxy-4-androsten-3-one | (+)-Cembrene | 2-Acetyl-1-alkyl-sn-glycero-3-phosphate | AB-FUBINACA | 4 | replace |
7,512 | C16H17NO3の異なる表現は? | Nitrendipine | Peiminoside | (3beta,5alpha,13beta,19alpha)-1,2-Didehydro-crinan-3-ol | Geranyl-hydroxybenzoate | L-Firefly luciferyl-CoA | 2 | replace |
11,884 | アルソールの別呼称は? | p-Chloromercuribenzoic acid | beta-D-Glucosyl-(1->4)-D-galactose | Alsol | 2-Oxo-1,2-dihydroquinoline-4-carboxylate | Ceceline | 2 | replace |
23,095 | Kniest dysplasia SUPERGRP Type II collagenopathies の別の呼び方は? | 小脳萎縮を伴う小児発症神経変性疾患 | 先天性横隔膜ヘルニア | 福山型先天性筋ジストロフィー 上位グループ 筋ジストロフィー・ジストログリカノパチー A型 先天性筋ジストロフィー 筋ジストロフィー・ジストログリカノパチー | Kniest 異形成症 上位グループ II 型コラーゲン異常症 | 肺動脈弁上狭窄を伴う網膜動脈瘤 | 3 | replace |
21,626 | C21H19N3O4の異なる表現は? | クロラムフェニコールコハク酸エステルナトリウム (JP18) | Cocaine (USP) | Sabizabulin (USAN/INN) | セフトロザン硫酸塩・タゾバクタムナトリウム | Oxtriphylline (USP) | 2 | replace |
14,809 | C18H31O16(C12H20O10)nの別名称は? | Cyanthoate | 1,6-alpha-D-Mannosyl-1,6-alpha-D-mannosyloligosaccharide | 5-Dehydro-D-fructose | (1R,6R)-1,4,5,5a,6,9-Hexahydrophenazine-1,6-dicarboxylate | Pateamine | 1 | replace |
5,344 | 7-Carboxy-7-deazaguanineをを組成式で表すと? | C11H14O2 | C16H18N3S. Cl | C25H28O12 | C29H20ClN7O11S3 | C7H6N4O3 | 4 | formula |
4,584 | 4,4'-Dihydroxy-alpha-methylstilbeneをを化学構造で記述すると? | CH2NO2R | C21H41N5O12 | C15H14O2 | C25H41NO7PR2 | C4H8O2 | 2 | formula |
16,438 | Pefcalcitol (JAN/USAN/INN)をを組成式で書くと? | C6504H10074N1758O2004S46 | C19H16ClFN3O5S. Na | C23H26Cl2O6 | C21H20F5N3O4 | C26H34F5NO4 | 4 | formula |
14,882 | C9H8ClN5Sの別の呼び方は? | (15Z)-Tetracosenoic acid | モグロシド IE | D-アロース | trans-Oct-2-enoyl-[acp] | チザニジン | 4 | replace |
4,785 | Dodecylcarboxylateの異なる名称は? | Methanesulfinic acid | Phylloquinone epoxide | Lauric acid | 5-Hydroxy-12-oxo-Delta5,8,11,14-eicosapolyenoic acid | Loganate | 2 | replace |
21,870 | C6440H9978N1724O2022S50の別の言い方は? | Telisotuzumab (USAN) | Varicella virus antigen | Dicopac kit (TN) | Proheparum (TN) | Betimol (TN) | 0 | replace |
8,736 | スルファドキシンを言い換えると? | A 80987 | MC-338 | Aminobacteriohopanetriol | Sulfadoxine | 4-O-beta-D-Mannopyranosyl-N-acetyl-D-glucosamine | 3 | replace |
32,828 | セントルイス脳炎 上位グループ 蚊媒介ウイルス性脳炎 の異なる表記は? | 3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency | Fechtner syndrome SUPERGRP MYH9-related disease Macrothrombocytopenia | Saint Louis encephalitis SUPERGRP Mosquito-borne viral encephalitis | Capnocytophaga canimorsus infection | Generalized epilepsy and paroxysmal dyskinesia | 2 | replace |
22,232 | dSMPをの化学構造は? | C19H24N2O | C14H19N6O10P | C30H18O10 | C15H24N5O8P | C18H35N5O6 | 1 | formula |
20,451 | Valnoctamide (USAN/INN)をを分子式で表すと? | C22H29N3O5 | C12H21N | C16H12ClFN2O | C24H40O5 | C8H17NO | 4 | formula |
Dataset Card for Nayose-Bench-Instruction
This dataset was created as a benchmark for the entity resolution task in the pharmaceutical domain.
Dataset Details
This dataset is designed for the entity resolution task in the pharmaceutical domain. The entity resolution task refers to a paraphrasing task, such as rephrasing drug names, converting chemical substances into brand names, or rewriting chemical substances into chemical formulas.
Uses
from datasets import load_dataset
load_dataset("EQUES/Nayose-Bench-QA")
{
"id": 7542,
"question": "イベルドミド塩酸塩の別表現は?",
"choice0": "イムガツズマブ",
"choice1": "Plusonermin (JAN)",
"choice2": "Iberdomide hydrochloride (USAN)",
"choice3": "ハートナップ病",
"choice4": "カルメグリプチン二塩酸塩",
"label": 2,
"task": "replace"
}
Dataset Structure
The data is stored in a JSONL file, where each record consists of the following fields: "id"
, "question"
, "choice0"
, "choice1"
, "choice2"
, "choice3"
, "choice4"
, "label"
, "task"
.
Example:
{"id": 30512, "question": "トリプロピオン酸エストリオールの別呼称は?", "choice0": "シデフェロン (JAN)", "choice1": "Lemildipine (JAN/INN)", "choice2": "アッシャー症候群", "choice3": "ナファゾリン塩酸塩・マレイン酸フェニラミン", "choice4": "Estriol tripropionate (JAN)", "label": 4, "task": "replace"}
Source Data
This dataset was created by processing the KEGG DRUG Database, a database that centrally aggregates pharmaceutical information from the perspective of chemical structures and components.
Dataset Creater
Created by Takuro Fujii (tkr.fujii.ynu@gmail.com)
Acknowledgement
本データセットは、経済産業省及び国立研究開発法人新エネルギー・産業技術総合開発機構(NEDO)による生成AI開発力強化プロジェクト「GENIAC」により支援を受けた成果の一部である。
- Downloads last month
- 111